CLINICAL_TRIALS
trial_result
· 2013-06-21
Clinical Trial Update: A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione [Phase 2]
Summary
A Phase 2 trial evaluating TT223 in patients with type 2 diabetes who are taking metformin and/or thiazolidinedione; the study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: OPKO Health, Inc. | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED